Ceramide levels are inversely associated with malignant progression of human glial tumors

Laura Riboni, Rolando Campanella, Rosaria Bassi, Roberto Villani, Sergio M. Gaini, Filippo Martinelli-Boneschi, Paola Viani, Guido Tettamanti

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Ceramide represents an important sphingoid mediator involved in the signaling pathways that control cell proliferation, differentiation, and death. To determine whether ceramide levels correlate with the malignant progression of human astrocytomas, we investigated these levels in surgical specimens of glial tumors of low-grade and high-grade malignancy. Tumor samples obtained from 52 patients who underwent therapeutic removal of primary brain tumors were used. The tumors were classified according to standard morphologic criteria and were grouped into tumors of low-grade and high-grade malignancy. Sections of normal brain tissue adjacent to the tumor were also analyzed in 11 of the 52 patients. After extraction and partial purification, ceramide was measured by quantitative derivatization to ceramide-1-phosphate using diacylglycerol kinase and [γ- 32P]ATP. Ceramide levels were significantly lower in the combined high-grade tumors compared with low-grade tumors and in both tumor groups compared with peritumoral tissue. The results indicate an inverse correlation between the amount of ceramide and tumor malignancy as assessed by both the histological grading and ganglioside pattern. Moreover, overall survival analysis of 38 patients indicates that ceramide levels are significantly associated with patient survival. The present findings indicate that ceramide is inversely associated with malignant progression of human astrocytomas and poor prognosis. The downregulation of ceramide levels in human astrocytemas emerges as a novel alteration that may contribute to glial neoplastic transformation. The low ceramide levels in high-grade tumors may provide an advantage for their rapid growth and apoptotic resistant features. This study appears to support the rationale for the potential benefits of a ceramide-based chemotherapy.

Original languageEnglish
Pages (from-to)105-113
Number of pages9
JournalGLIA
Volume39
Issue number2
DOIs
Publication statusPublished - 2002

Fingerprint

Ceramides
Neuroglia
Neoplasms
Astrocytoma
Diacylglycerol Kinase
Gangliosides
Survival Analysis
Brain Neoplasms
Cell Differentiation
Cell Death
Down-Regulation
Adenosine Triphosphate

Keywords

  • Human astrocytomas
  • Malignant progression
  • Sphingoid mediators

ASJC Scopus subject areas

  • Immunology

Cite this

Riboni, L., Campanella, R., Bassi, R., Villani, R., Gaini, S. M., Martinelli-Boneschi, F., ... Tettamanti, G. (2002). Ceramide levels are inversely associated with malignant progression of human glial tumors. GLIA, 39(2), 105-113. https://doi.org/10.1002/glia.10087

Ceramide levels are inversely associated with malignant progression of human glial tumors. / Riboni, Laura; Campanella, Rolando; Bassi, Rosaria; Villani, Roberto; Gaini, Sergio M.; Martinelli-Boneschi, Filippo; Viani, Paola; Tettamanti, Guido.

In: GLIA, Vol. 39, No. 2, 2002, p. 105-113.

Research output: Contribution to journalArticle

Riboni, L, Campanella, R, Bassi, R, Villani, R, Gaini, SM, Martinelli-Boneschi, F, Viani, P & Tettamanti, G 2002, 'Ceramide levels are inversely associated with malignant progression of human glial tumors', GLIA, vol. 39, no. 2, pp. 105-113. https://doi.org/10.1002/glia.10087
Riboni L, Campanella R, Bassi R, Villani R, Gaini SM, Martinelli-Boneschi F et al. Ceramide levels are inversely associated with malignant progression of human glial tumors. GLIA. 2002;39(2):105-113. https://doi.org/10.1002/glia.10087
Riboni, Laura ; Campanella, Rolando ; Bassi, Rosaria ; Villani, Roberto ; Gaini, Sergio M. ; Martinelli-Boneschi, Filippo ; Viani, Paola ; Tettamanti, Guido. / Ceramide levels are inversely associated with malignant progression of human glial tumors. In: GLIA. 2002 ; Vol. 39, No. 2. pp. 105-113.
@article{abef42b79516444ea19042c5d4a5f1bd,
title = "Ceramide levels are inversely associated with malignant progression of human glial tumors",
abstract = "Ceramide represents an important sphingoid mediator involved in the signaling pathways that control cell proliferation, differentiation, and death. To determine whether ceramide levels correlate with the malignant progression of human astrocytomas, we investigated these levels in surgical specimens of glial tumors of low-grade and high-grade malignancy. Tumor samples obtained from 52 patients who underwent therapeutic removal of primary brain tumors were used. The tumors were classified according to standard morphologic criteria and were grouped into tumors of low-grade and high-grade malignancy. Sections of normal brain tissue adjacent to the tumor were also analyzed in 11 of the 52 patients. After extraction and partial purification, ceramide was measured by quantitative derivatization to ceramide-1-phosphate using diacylglycerol kinase and [γ- 32P]ATP. Ceramide levels were significantly lower in the combined high-grade tumors compared with low-grade tumors and in both tumor groups compared with peritumoral tissue. The results indicate an inverse correlation between the amount of ceramide and tumor malignancy as assessed by both the histological grading and ganglioside pattern. Moreover, overall survival analysis of 38 patients indicates that ceramide levels are significantly associated with patient survival. The present findings indicate that ceramide is inversely associated with malignant progression of human astrocytomas and poor prognosis. The downregulation of ceramide levels in human astrocytemas emerges as a novel alteration that may contribute to glial neoplastic transformation. The low ceramide levels in high-grade tumors may provide an advantage for their rapid growth and apoptotic resistant features. This study appears to support the rationale for the potential benefits of a ceramide-based chemotherapy.",
keywords = "Human astrocytomas, Malignant progression, Sphingoid mediators",
author = "Laura Riboni and Rolando Campanella and Rosaria Bassi and Roberto Villani and Gaini, {Sergio M.} and Filippo Martinelli-Boneschi and Paola Viani and Guido Tettamanti",
year = "2002",
doi = "10.1002/glia.10087",
language = "English",
volume = "39",
pages = "105--113",
journal = "GLIA",
issn = "0894-1491",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Ceramide levels are inversely associated with malignant progression of human glial tumors

AU - Riboni, Laura

AU - Campanella, Rolando

AU - Bassi, Rosaria

AU - Villani, Roberto

AU - Gaini, Sergio M.

AU - Martinelli-Boneschi, Filippo

AU - Viani, Paola

AU - Tettamanti, Guido

PY - 2002

Y1 - 2002

N2 - Ceramide represents an important sphingoid mediator involved in the signaling pathways that control cell proliferation, differentiation, and death. To determine whether ceramide levels correlate with the malignant progression of human astrocytomas, we investigated these levels in surgical specimens of glial tumors of low-grade and high-grade malignancy. Tumor samples obtained from 52 patients who underwent therapeutic removal of primary brain tumors were used. The tumors were classified according to standard morphologic criteria and were grouped into tumors of low-grade and high-grade malignancy. Sections of normal brain tissue adjacent to the tumor were also analyzed in 11 of the 52 patients. After extraction and partial purification, ceramide was measured by quantitative derivatization to ceramide-1-phosphate using diacylglycerol kinase and [γ- 32P]ATP. Ceramide levels were significantly lower in the combined high-grade tumors compared with low-grade tumors and in both tumor groups compared with peritumoral tissue. The results indicate an inverse correlation between the amount of ceramide and tumor malignancy as assessed by both the histological grading and ganglioside pattern. Moreover, overall survival analysis of 38 patients indicates that ceramide levels are significantly associated with patient survival. The present findings indicate that ceramide is inversely associated with malignant progression of human astrocytomas and poor prognosis. The downregulation of ceramide levels in human astrocytemas emerges as a novel alteration that may contribute to glial neoplastic transformation. The low ceramide levels in high-grade tumors may provide an advantage for their rapid growth and apoptotic resistant features. This study appears to support the rationale for the potential benefits of a ceramide-based chemotherapy.

AB - Ceramide represents an important sphingoid mediator involved in the signaling pathways that control cell proliferation, differentiation, and death. To determine whether ceramide levels correlate with the malignant progression of human astrocytomas, we investigated these levels in surgical specimens of glial tumors of low-grade and high-grade malignancy. Tumor samples obtained from 52 patients who underwent therapeutic removal of primary brain tumors were used. The tumors were classified according to standard morphologic criteria and were grouped into tumors of low-grade and high-grade malignancy. Sections of normal brain tissue adjacent to the tumor were also analyzed in 11 of the 52 patients. After extraction and partial purification, ceramide was measured by quantitative derivatization to ceramide-1-phosphate using diacylglycerol kinase and [γ- 32P]ATP. Ceramide levels were significantly lower in the combined high-grade tumors compared with low-grade tumors and in both tumor groups compared with peritumoral tissue. The results indicate an inverse correlation between the amount of ceramide and tumor malignancy as assessed by both the histological grading and ganglioside pattern. Moreover, overall survival analysis of 38 patients indicates that ceramide levels are significantly associated with patient survival. The present findings indicate that ceramide is inversely associated with malignant progression of human astrocytomas and poor prognosis. The downregulation of ceramide levels in human astrocytemas emerges as a novel alteration that may contribute to glial neoplastic transformation. The low ceramide levels in high-grade tumors may provide an advantage for their rapid growth and apoptotic resistant features. This study appears to support the rationale for the potential benefits of a ceramide-based chemotherapy.

KW - Human astrocytomas

KW - Malignant progression

KW - Sphingoid mediators

UR - http://www.scopus.com/inward/record.url?scp=0035983292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035983292&partnerID=8YFLogxK

U2 - 10.1002/glia.10087

DO - 10.1002/glia.10087

M3 - Article

VL - 39

SP - 105

EP - 113

JO - GLIA

JF - GLIA

SN - 0894-1491

IS - 2

ER -